Granules India spurts as its arm enters into agreement for product in-licensing

10 Jun 2016 Evaluate

Granules India is currently trading at Rs 142.95, up by 0.85 points or 0.60% from its previous closing of Rs. 142.10 on the BSE.

The scrip opened at Rs. 143.00 and has touched a high and low of Rs. 145.90 and Rs. 142.10 respectively. So far 202450 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 164.45 on 01-Dec-2015 and a 52 week low of Rs. 75.55 on 12-Jun-2015.

Last one week high and low of the scrip stood at Rs. 143.90 and Rs. 137.90 respectively. The current market cap of the company is Rs. 3107.65 crore.

The promoters holding in the company stood at 51.15% while Institutions and Non-Institutions held 7.59% and 41.26% respectively.

Granules India’s wholly owned subsidiary - Granules Pharmaceuticals, Inc., (GPI) has acquired the exclusive rights from USpharma Windlas, LLC to market and distribute four products in the USA. USpharma Windlas through its subsidiaries (First time US Generics and Liberty) holds Abbreviated New Drug Applications (ANDAs) for Fingolimod, Prasugrel, Dronedarone and Lurasidone. USpharma Windlas believes to be a first applicant to file ANDAs containing paragraph IV certifications for three of these products.

USpharma Windlas will receive milestone payments and share of the profits from commercial sales. Granules Pharmaceuticals, Inc. will be responsible for the marketing and distribution of the products in the United States, subject to final approval by the US Food and Drug Administration (USFDA). According to IMS Health data, the annual US sales for above four products are approximately $4.4 billion.

Granules India produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

Granules India Share Price

593.90 -12.00 (-1.98%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.